AAAAAA

   
Results: 1-14 |
Results: 14
THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL
Authors: VOSE J COLCHER D BIERMAN P GOBAR L HOHENSTEIN M AUGUSTINE S GOLDENBERG D TEMPERO M ARMITAGE J
Citation: J. Vose et al., THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 7-7
THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL
Authors: VOSE J COLCHER D BIERMAN P GOBAR L HOHENSTEIN M AUGUSTINE S GOLDENBERG D TEMPERO M ARMITAGE J
Citation: J. Vose et al., THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 45-45
DEVELOPMENTS IN SYSTEMIC THERAPY OF PANCREATIC-CANCER
Authors: TEMPERO M
Citation: M. Tempero, DEVELOPMENTS IN SYSTEMIC THERAPY OF PANCREATIC-CANCER, European journal of cancer, 33, 1997, pp. 607-607
HIGH-DOSE THERAPY WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY CC49 INPATIENTS WITH GASTROINTESTINAL CANCERS - A PHASE-I TRIAL
Authors: TEMPERO M LEICHNER P DALRYMPLE G HARRISON K AUGUSTINE S SCHLOM J ANDERSON J WISECARVER J COLCHER D
Citation: M. Tempero et al., HIGH-DOSE THERAPY WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY CC49 INPATIENTS WITH GASTROINTESTINAL CANCERS - A PHASE-I TRIAL, Journal of clinical oncology, 15(4), 1997, pp. 1518-1528
ANTIIDIOTYPIC RESPONSE AGAINST MURINE MONOCLONAL-ANTIBODIES REACTIVE WITH TUMOR-ASSOCIATED ANTIGEN TAG-72
Authors: BLANCO I KAWATSU R HARRISON K LEICHNER P AUGUSTINE S BARANOWSKAKORTYLEWICZ J TEMPERO M COLCHER D
Citation: I. Blanco et al., ANTIIDIOTYPIC RESPONSE AGAINST MURINE MONOCLONAL-ANTIBODIES REACTIVE WITH TUMOR-ASSOCIATED ANTIGEN TAG-72, Journal of clinical immunology, 17(1), 1997, pp. 96-106
A PHASE-I TRIAL OF WEEKLY GEMCITABINE ADMINISTERED AS A PROLONGED INFUSION IN PATIENTS WITH PANCREATIC-CANCER AND OTHER SOLID TUMORS
Authors: BRAND R CAPADANO M TEMPERO M
Citation: R. Brand et al., A PHASE-I TRIAL OF WEEKLY GEMCITABINE ADMINISTERED AS A PROLONGED INFUSION IN PATIENTS WITH PANCREATIC-CANCER AND OTHER SOLID TUMORS, Investigational new drugs, 15(4), 1997, pp. 331-341
I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) - RESULTS OF A REPETITIVE DOSING TRIAL
Authors: VOSE J COLCHER D BIERMAN P LEICHNER P AKABANI G HARRISON K HOHENSTEIN M LESSER S HAMMERSHAIMB L GOLDENBERG DM TEMPERO M ARMITAGE J
Citation: J. Vose et al., I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) - RESULTS OF A REPETITIVE DOSING TRIAL, The Journal of nuclear medicine, 38(5), 1997, pp. 211-211
THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL
Authors: VOSE J COLCHER D BIERMAN P LEICHNER P AKABANI G HARRISON K HOHENSTEIN M LESSER S HAMMERSHAIMB L GOLDENBERG DM TEMPERO M ARMITAGE J
Citation: J. Vose et al., THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL, Blood, 88(10), 1996, pp. 2258-2258
MALIGNANCIES AFTER LIVER-TRANSPLANTATION - A COMPARATIVE REVIEW
Authors: TANSHALABY J TEMPERO M
Citation: J. Tanshalaby et M. Tempero, MALIGNANCIES AFTER LIVER-TRANSPLANTATION - A COMPARATIVE REVIEW, Seminars in liver disease, 15(2), 1995, pp. 156-164
NEW IMAGING TECHNIQUES IN COLORECTAL-CANCER
Authors: TEMPERO M BRAND R HOLDEMAN K MATAMOROS A
Citation: M. Tempero et al., NEW IMAGING TECHNIQUES IN COLORECTAL-CANCER, Seminars in oncology, 22(5), 1995, pp. 448-471
AN OVERVIEW OF MONOCLONAL-BASED THERAPY IN PANCREATIC-CANCER
Authors: TEMPERO M COLCHER D
Citation: M. Tempero et D. Colcher, AN OVERVIEW OF MONOCLONAL-BASED THERAPY IN PANCREATIC-CANCER, International journal of pancreatology, 16(2-3), 1994, pp. 300-302
CLINICAL-MODELS AND FEASIBLE STRATEGIES FOR INTERVENING IN EARLY-STAGE DISEASE
Authors: TEMPERO M
Citation: M. Tempero, CLINICAL-MODELS AND FEASIBLE STRATEGIES FOR INTERVENING IN EARLY-STAGE DISEASE, International journal of pancreatology, 16(2-3), 1994, pp. 307-307
PROGRESS IN COLON-CANCER - DO MOLECULAR MARKERS MATTER
Authors: TEMPERO M ANDERSON J
Citation: M. Tempero et J. Anderson, PROGRESS IN COLON-CANCER - DO MOLECULAR MARKERS MATTER, The New England journal of medicine, 331(4), 1994, pp. 267-268
PITFALLS IN ANTIBODY IMAGING IN COLORECTAL-CANCER
Authors: TEMPERO M
Citation: M. Tempero, PITFALLS IN ANTIBODY IMAGING IN COLORECTAL-CANCER, Cancer, 71(12), 1993, pp. 4248-4251
Risultati: 1-14 |